1. Agarwal VR, Takayama K, Van Wyk JJ, et al. Molecular basis of severe gynecomastia associated with aromatase expression in fibrolamellar hepatocellular carcinoma. J Clin Endocrinol Metab 1998;83:1797-1800

2. Andreu V, Elizalde I, Mallafre C, et al. Plexiform neurofibromatosis and angiosarcoma of the liver in von Recklinghausen Disease. Am J Gastroenterol 1997;92:1229-1230

3. Baker ME, Paulson EK. Hepatic metastatic disease. In: Meyers MA (ed): Neoplasms of the Digestive Tract: Imaging, Staging and Management. Philadelphia: Lippincott-Raven;1998:361-395

4. Bartolozzi C, Cioni D, Donati F, et al. Focal liver lesions: MR imaging-pathologic correlation. Eur Ra-diol 2001;11:1374-1388

5. Basilico R, Blomley MJ, Harvey CJ, et al. Which continuous US scanning mode is optimal for the detection of vascularity in liver lesions when enhanced with a second generation contrast agent? Eur J Radi-ol 2002;41:184-191

6. Berman MM, Libbey NP, Foster JH. Hepatocellular carcinoma. Polygonal cell type with fibrous stroma -an atypical variant with a favorable prognosis. Cancer 1980;46:1448-1455

7. Biemer JJ. Hepatic manifestation of lymphomas. Ann Clin Lab Sci1984;14:252-260

8. Bluemke DA, Soyer P, Fishman E. Helical (spiral) CT of the liver. Radiol Clin North Am 1995;33:863-886

9. Brady J, Liberatore F, Harper P, et al. Angiosarcoma of the liver: an epidemiology survey. J Natl Cancer Inst 1977;59:1383-1385

10. Brandt DJ, Johnson CD, Stephens DH, et al. Imaging of fibrolamellar hepatocellular carcinoma. AJR Am J Roentgenol 1988;151:295-299

11. Buetow PC, Buck JL, Ros PR, et al. Malignant vascular tumors of the liver: radiologic-pathologic correlation. Radiographics 1994;14:153-166

12. Caudana R, Morana G, Pirovano GP, et al. Focal Malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOP-ta) -preliminary results of phase II clinical application. Radiology 1996;199:513-520

13. Chen IY, Katz DS, Jeffrey RB, et al. Do arterial phase helical CT images improve detection or characterization of colorectal liver metastases? J Comput Assist Tomogr 1997;21(3):391-397

14. Chiao R, Mo L, Hall A, et al. B-mode blood flow imaging. AIUM Annual Convention, San Francisco, California, USA, April 2-5, 2000

15. Choi BI, Han JK, Hong SH, et al. Dysplastic nodules of the liver: imaging findings. Abdom Imaging 1999;24:250-257

16. Choi BI, Kim CW, Ham MC, et al. Sonographic characteristics of small hepatocellular carcinoma. Gastrointestinal Radiol 1989;14:255-261

17. Choi BI, Takayasu K, Han MC. Small hepatocellular carcinomas and associated nodular lesions of the liver: pathology, pathogenesis and imaging findings. AJR Am J Roentgenol 1993;160:1177-1187

18. Collier JD, Carpenter M, Burt AD, et al. Expression of mutant p53 protein in hepatocellular carcinoma. Gut 1994:35:98-100

19. Corrigan K, Semelka RC. Dynamic contrast-enhanced MR imaging of fibrolamellar hepatocellular carcinoma. Abdom Imaging 1995;20:122-125

20. Craig JR, Peters RL, Edmondson HA, et al. Fibro-lamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinco-pathologic features. Cancer 1980;46:372-379

21. Fernandez MP, Redvanly RD. Primary hepatic malignant neoplasms. Radiol Clin North Am 1998;36:333-348

22. Enwonwu CO. The role of dietary aflatoxin in the genesis of hepatocellular cancer in developing countries. Lancet 1984;2:956-958

23. Enzinger FM, Weiss SW. Soft-tissue Tumors. Mosby Year-Book, St. Louis, 1983

24. Freeny PC, Baron RL, Teefey SA. Hepatocellular carcinoma: reduced frequency of typical findings with dynamic contrast-enhanced CT in a non-Asian population. Radiology 1992;182:143-148

25. Friedman AC, Lichtenstein JE, Goodman Z, et al. Fi-brolamellar hepatocellular carcinoma. Radiology 1985;157:583-587

26. Fukayama M, Nihei Z, Takizawa T, et al. Malignant epithelioid hemangioendothelioma of the liver, spreading through the hepatic veins. Virchows Arch A Pathol Anat Histopathol 1984;404:275-287

27. Furui S, Itai Y, Ohtomo K, et al. Hepatic epithelioid hemangioendothelioma: report of five cases. Radiology 1989;171:63-68

28. Gabata T, Matsui O, Kadoya M, et al. Delayed MR imaging of the liver: correlation of delayed enhancement of hepatic tumors and pathologic appearance. Abdom Imaging 1998;23:309-313

29. Gates LK Jr, Cameron AJ, Nagorney DM, et al. Primary leiomyosarcoma of the liver mimicking liver abscess. Am J Gastroenterol 1995;90:649-652

30. Goodman ZD. Nonparenchymal and metastatic malignant tumors of the liver. In: Haubrich WS, Schaffner F, Berk JE (eds): Bockus Gastroenterolo-gy. Philadelphia: WB Saunders, 1995;2488-2500

31. Grazioli L, Morana G, Caudana R, et al. Hepatocel-lular carcinoma: correlation between gadobenate dimeglumine-enhanced MRI and pathologic findings. Invest Radiol 2000;35:25-34

32. Grazioli L, Olivetti L, Fugazzola C, et al. The pseudocapsule in hepatocellular carcinoma: correlation between dynamic MR imaging and pathology. Eur Ra-diol 1999;9:62-67

33. Hagspiel KD, Neidl KF, Eichenberger AC, et al. Detection of liver metastases: comparison of super-paramagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US and percutanous US. Radiology 1995;196:471-478

34. Hammerstingl R, Vogl TJ Schwarz W,. Contrast-enhanced MRI of focal liver lesions: differentiation and detection of primary and secondary liver lesions using Resovist-enhanced versus gadolinium-enhanced MRI in the same patient. Acad Radiol 1998;5(Suppl 1):75-79

35. Hardell L, Bengtsson NO, Jonsson U, et al. Aetiolog-ical aspects of primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria - an epidemiological investigation. Br J Cancer 1984;50:389-397

36. Harris KM, Schwartz ML, Slasky BS, et al. Posttransplantation cyclosporine-induced lymphoprolifera-tive disorders: clinical and radiologic manifestations. Radiology 1987;162;697-700

37. Hayashi M, Matsui O, Ueda K, et al. Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. AJR Am J Roentgenol 1999;172:969-976

38. Hollett MD, Jeffrey RB Jr, Nino-Murcia M, et al. Dual-phase helical CT of the liver: value of arterial phase scans in the detection of small (< or = 1.5 cm) malignant hepatic neoplasms. AJR Am J Roentgenol 1995;164:879-884

39. Ichikawa T, Federle MP, Grazioli L, et al. Fibro-lamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases. Radiology 1999;213:352-361

40. Imai Y, Murakami T, Yoshida S, et al. Superpara-magnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology 2000;32:205-212

41. Ishak KG, Sesterhenn IA, Goodman ZD, et al. Ep-ithelioid hemangioendothelioma of the liver: a clin-icopathologic and follow-up study of 32 cases. Hum Pathol 1984;15:839-852

42. Ishak KG. Malignant mesenchymal tumors of the liver. In: Okuda K, Ishak KG (eds): Neoplasms of the liver. Springer Verlag, New York, 1988,121-156

43. Ishak KG. Mesenchymal tumors of the liver. In Oku-da K, Peter RL (eds): Hepatocellular Carcinoma. John Wiley & Sons, New York, 1976,228-587

44. Ishak KG. Pathogenesis of liver iseases. In: Farber E, Philips MJ, Kaufman N (eds): International Academy of Pathology Monograph, No. 28, Williams & Wilkins, Baltimore, 1987,314-315

45. Itai Y, Matsui O. Blood flow and liver imaging. Radiology 1997;202:306-314

46. Ito Y, Kojiro M, Nakshima T, et al. Pathomorphology characteristics of 102 cases of thorotrast-relat-ed hepatocellular carcinoma, cholangiocarcinoma, and hepatic angiosarcoma. Cancer 1988;62:1153-1162

47. Jaffe ES. Malignant lymphomas: pathology of hepatic involvement. Semin Liver Dis 1987;7:257-268

48. Jang HJ, Lim HK, Lee WJ, et al. Ultrasonographic evaluation of focal hepatic lesions: comparison of pulse inversion harmonic, tissue harmonic, and conventional imaging techniques. J Ultrasound Med 2000;19:293-299

49. Kew MC. Hepatic tumors and cysts. In: Feldman M, Scharschmidt BF, Sleisenger MH (eds): Sleisenger and Fordtran's Gastrointestinal and Liver Disease (6th ed). WB Saunders, Philadelphia, 1998,13641387

50. Kim AY, Choi BI, Kim TK, et al. Hepatocellular carcinoma: power Doppler US with a contrast agent -preliminary results. Radiology 1998;209:135-140

51. Kim T, Murakami T, Takahashi S, et al. Optimal phases of dynamic CT for detecting hepatocellular carcinoma: evaluation of unenhanced and triple-phase images. Abdom Imaging 1999;24:473-480

52. Kojiro M, Nakashima T. Pathology of hepatocellular carcinoma. In: Okuda K, Ishak KG (eds): Neoplasms of the Liver. Springer-Verlag, New York, 1987,81-104

53. Kojiro M. Hepatocellular nodular lesions. In: Kojiro M (ed): Pathology of Early Hepatocellular Carcinoma and Related Lesions. Medical Publishers, Tokyo, 1996;148-165

54. Krinsky GA, Lee VS, Theise ND, et al. Hepatocellu-lar carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explanation correlation. Radiology 2001;219:445-454

55. Kuszyk BS, Bluemke DA, Urban BA, et al. Portalphase contrast-enhanced helical CT for the detection of malignant hepatic tumors: sensitivity based on comparison with intraoperative and pathologic findings. AJR Am J Roentgenol 1996;166:91-95

56. LaBrecque DR. Neoplasia of the liver: focal nodular hyperplasia. In: Kaplowitz N (ed): Liver and Biliary Diseases (2nd ed): Williams & Wilkins, Baltimore, 1996, 391-438

57. Lai C, Gregory PB, Wu P, et al. Hepatocellular carcinoma in Chinese males and females: Possible causes for male predominance. Cancer 1987;60:1107-1110

58. Lauffer JM, Zimmermann A, Krahenbuhl L, et al. Epithelioid hemangioendothelioma of the liver. Cancer 1996:78(11):2318-2327

59. Lencioni R, Pinto F, Armillotta N, et al. Assessment of tumor vascularity in hepatocellular carcinoma: comparison of power Doppler US and color Doppler US. Radiology 1996;201:353-358

60. Lewis KH, Chezmar JL. Hepatic metastases. Magn Reson Imaging Clin N Am 1997;5:319-330

61. Lim JH, Cho JM, Kim EY, et al. Dysplastic nodules in liver cirrhosis: evaluation of hemodynamics with CT during arterial portography and CT hepatic arteri-ography. Radiology 2000;214:869-874

62. Lim JH, Choi D, Cho SK, et al. Conspicuity if hepa-tocellular nodular lesions in cirrhotic livers at feru-moxides-enhanced MR imaging: importance of Kupffer cell number. Radiology 2001;220:669-676

63. Locker GY, Doroshow JH, Zwelling LA, et al. The clinical features of hepatic angiosarcoma: a report of four cases and a review of the English literature. Medicine, (Baltimore) 1979;58:48-64

64. Manfredi R, Maresca G, Baron RL, et al. Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenate dimeglumine (Gd-BOPTA). J Magn Re-son Imaging 1999;9:704-710

65. Marti-Bonmati L, Ferrer D, Menor F, et al. Hepatic mesenchymal sarcoma: MRI findings. Abdom Imaging 1993;18:176-179

66. McLarney JK, Rucker PT, Bender GN et al. Fibro-lamellar carcinoma of the liver: radiologic-patho-logic correlation. Radiographics 1999;19:453-471

67. Miller WJ, Dodd GD 3rd, Federle MP, et al. Epithe-lioid hemangioendothelioma of the liver: imaging findings with pathologic correlation. AJR Am J Roentgenol 1992;159:53-57

68. Murakami T, Baron RL, Peterson MS, et al. Hepato-cellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP). Radiology 1996;200:69-77

69. Murakami T, Kim T, Takamura M, et al. Hepatitis, cirrhosis and hepatoma. J Magn Reson Imaging 1998;8:346-358

70. Murakami T, Kim T, Takamura M, et al. Hypervas-cular hepatocellular carcinoma: detection with double arterial phase multi-detector row helical CT. Ra-diology2001;218:763-767

71. Nakashima T, Kojiro M. Hepatocellular carcinoma: An Atlas of its Pathology. Springer-Verlag, Tokyo, 1987

72. Nerlich AG, Majewski S, Hunzelmann N, et al. Excessive collagen formation in fibrolamellar carcino ma of the liver: a morphological and biochemical study. Mod Pathol 1992;5:580-585

73. Noguchi S, Yamamoto R, Tatsuta M, et al. Cell features and patterns in fine-needle aspirates of hepa-tocellular carcinoma. Cancer 1986;58:321-328

74. Nzeako UC, Goodman ZD, Ishak KG. Hepatocellu-lar carcinoma in cirrhotic and noncirrhotic livers: a clinico-histopathologic study of 804 North American patients. Am J Clin Pathol 1996;105:65-75

75. Ohsawa M, Aozasa K, Horiuchi K, et al. Malignant lymphoma of the liver. Report of five cases and review of the literature. Dig Dis Sci 1992;37:1105-1109

76. Oliver JH 3rd, Baron RL, Federle MP, et al. Detecting hepatocellular carcinoma: value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging. AJR Am J Roentgenol 1996;167:71-77

77. Orsatti G, Hytiroglou P, Thung SN, et al. Lamellar fi-brosis in the fibrolamellar variant of hepatocellular carcinoma: a role for transforming growth factor beta. Liver 1997;17:152-156

78. Parker SL, Tong T, Bolden S, et al. Cancer statistics. CA Cancer J Clin 1997;47:5-27

79. Paulson EK. Evaluation of the liver for metastatic disease. Semin Liver Dis 2001;21(2):225-236

80. Peterson MS, Baron RL, Marsh JW, et al. Pretrans-plantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation. Radiology; 2000;217:743-749

81. Peterson MS, Baron RL, Rankin SC, et al. Hepatic angiosarcoma: findings on multiphasic contrast-enhanced helical CT do not mimic hepatic heman-gioma. AJR Am J Roentgenol 2000;175:165-170

82. Peterson MS, Murakami T, Baron RL. MR imaging patterns of gadolinium retention within liver neoplasms. Abdom Imaging 1998;23:592-599

83. Pinson CW, Lopez RR, Ivancev K, et al. Resection of primary hepatic malignant fibrous histiocytoma, fi-brosarcoma and leiomyosarcoma. South Med 1994;87:384-391

84. Rizzi EB, Schinina V, Cristofaro M, et al. Non-hodgkin's lymphoma of the liver in patients with AIDS: sonographic, CT and MRI findings. J Clin Ultrasound 2001;29:125-129

85. Rofsky NM, Earls JP. Mangafodipir trisodium injection (Mn-DPDP). A contrast agent for abdominal MR imaging. Magn Reson Imaging Clin N Am 1996;4:73-85

86. Ros PR, Murphy BJ, Buck JL, et al. Encapsulated he-patocellular carcinoma: radiologic findings and pathologic correlation. Gastrointest Radiol 1990;15:233-237

87. Ros PR, Taylor HM. Malignant Tumors of the liver. Textbook of gastrointestinal radiology, Vol II, second edition. Saunders, Philadelphia, 2000,1523-1568

88. Ros PR. Malignant liver tumors. In: Gore RM, Levine MS, Laufer I (eds): Gastrointestinal radiology. Saunders, Philadelphia, 1994,1897-1946

89. Runge VM, Lee C, Williams NM. Detectability of small liver metastases with gadolinium BOPTA. Invest Radiol 1997;32:557-565

90. Sakamoto M, Hirohashi S, Shimosato Y. Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 1991;22:172-178

91. Seneterre E, Taourel P, Bouvier Y, et al. Detection of hepatic metastases: ferumoxides-enhanced MR Imaging versus unenhanced MR Imaging and CT during arterial portography. Radiology 1996; 200:785-792

92. Sherlock S, Dooley J. Diseases of the liver and Biliary System (9th ed). Blackwell Scientific Publications, Oxford, 1993, 44-61

93. Shirkhoda A, Ros PR, Farah J, et al. Lymphoma of the solid abdominal viscera. Radiol Clin North Am 1990;28:785-799

94. Siskin GP, Haller JO, Miller S, et al. AIDS-related lymphoma: radiologic features in pediatric patients. Radiology 1995;196:63-66

95. Smalley SR, Moertel CG, Hilton JF, et al. He-patoma in the noncirrhotic liver. Cancer 1988;62:1414-1424

96. Soyer P, Roche A, Levesque M, et al. CT of fibro-lamellar hepatocellular carcinoma. J Computed Assist Tomogr 1991;15:533-538

97. Stevens WR, Johnson CD, Stephens DH, et al. Fi-brolamellar hepatocellular carcinoma: stage at presentation and results of aggressive surgical management. AJR Am J Roentgenol 1995; 164:1153-1158

98. Sussman EB, Nydick I, Gray GF. Hemangioen-dothelial sarcoma of the liver and hemochro-matosis. Arch Pathol 1974;97:39-42

99. Tamburro CH. Relationship of vinyl monomers and liver cancers: angiosarcoma and hepatocellu-lar carcinoma. Semin Liver Dis 1984;4:158-169

100. Van Beers B, Roche A, Mathieu D, et al. Epithelioid hemangioendothelioma of the liver: MR and CT findings. J Comput Assist Tomogr 1992;16:420-424

101. Wang C, Ahlstrom H, Ekholm S, et al. Diagnostic efficacy of MnDPDP in MR imaging of the liver. A phase III multicentre study. Acta Radiol 1997;38:643-649

102. Weiss SW, Enzinger FM. Epithelioid hemangioen-dothelioma: a vascular tumor often mistaken for a carcinoma. Cancer 1982;50:970-981

103. Wernecke K, Peters PE, Kruger KG. Ultrasonographic patterns of focal hepatic and splenic lesions in Hodgkin's and non-Hodgkin's lymphoma. Br J Radiol 1987;60:655-660

104. Winston CB, Schwartz LH, Fong Y, et al. Hepato-cellular carcinoma: MR imaging findings in cir-rhotic livers and noncirrhotic livers. Radiology 1999;210:75-79

105. Worawattanakul S, Semelka RC, Kelekis NL, et al. Angiosarcoma of the liver: MR imaging pre- and post chemotherapy. Magn Reson Imaging 1997;15:613-617

106. Yamashita Y, Fan ZM, Yamamoto H, et al. Spinecho and dynamic gadolinium-enhanced FLASH MR imaging of hepatocellular carcinoma: correlation with histopathologic findings. J Magn Reson Imaging 1994;4:83-90

107. Yu JS, Kim KW, Kim EK, et al. Contrast enhancement of small hepatocellular carcinoma: usefulness of three successive early image acquisitions during multiphase dynamic MR imaging. AJR Am J Roentgenol 1999;173:597-604

Was this article helpful?

0 0
10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment